Quality over quantity: biopsy-anchored CT radiogenomics models outperform all-lesion training in a multi-tumour cohort despite a smaller sample size - Summary - MDSpire

Quality over quantity: biopsy-anchored CT radiogenomics models outperform all-lesion training in a multi-tumour cohort despite a smaller sample size

  • By

  • Diana Ivonne Rodríguez Sánchez

  • Julian Middelkoop

  • Thera Vanneste

  • Olga Maxouri

  • Stephan Ursprung

  • Sajjad Rostami

  • Nino Bogveradze

  • Kalina Chupetlovska

  • Francesca Castagnoli

  • Federica Landolfi

  • Eun Kyoung Hong

  • Andrea Delli Pizzi

  • Nicolo Gennaro

  • Warissara Jutidamrongphan

  • Liliana Petrychenko

  • Petur Snaebjornsson

  • Zuhir Bodalal

  • Regina Beets-Tan

  • May 16, 2026

Share

Objective:

To evaluate whether restricting model training to biopsy-confirmed lesions improves external generalizability, which is crucial for addressing lesion-level molecular heterogeneity in EGFR-driven tumors.

Key Findings:
  • Biopsy-based training models outperformed all-lesion models in terms of external generalizability, indicating a potential shift in clinical practice.
  • Lesion-level label fidelity significantly improved reproducibility and interpretability of radiogenomic signatures, enhancing their clinical applicability.
  • The study highlights the importance of accounting for intra- and inter-tumoral heterogeneity in precision oncology, suggesting a need for refined diagnostic approaches.
Interpretation:

The findings suggest that using biopsy-confirmed lesions for training radiogenomic models enhances their reliability and applicability in clinical settings, effectively addressing the challenge of molecular heterogeneity in tumors and improving treatment strategies.

Limitations:
  • The study was retrospective, which may introduce biases that could affect the generalizability of the results.
  • Sample size for certain analyses was reduced when focusing on biopsy-confirmed lesions, potentially limiting the robustness of findings.
Conclusion:

Restricting training to biopsy-confirmed lesions leads to more robust radiogenomic models, supporting their use as a complement to traditional tissue testing in precision oncology.

Original Source(s)

Related Content